Active Ingredients
Bacitracin zinc 500 units
Neomycin 3.5 mg
Polymyxin B sulfate 10,000 units
Pramoxine hydrochloride 10 mg
Drs. Pharmacy Triple Antibiotic Plus Pain Relief
FDA Label NDC 80489-857
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Ol Pharma Tech, Llc Drs Pharmacy for the product Drs. Pharmacy Triple Antibiotic Plus Pain Relief (NDC 80489-857). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, uses, purpose, do not use, warnings, otc - ask doctor, otc - stop use, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Uses
first aid to help prevent infection in minor
• cuts
• scrapes
• burns
Purpose
- first aid antibiotic
- External Analgesic
Do Not Use
Do not use
• if you are allergic to any of the ingredients
• in the eyes
• over large areas of the body
• longer than 1 week unless directed by a doctor
Warnings
For external use only
Otc - Ask Doctor
Ask a doctor before use if you have
• deep or puncture wounds
• animal bites
• serious burns
Otc - Stop Use
Stop use and ask a doctor if
• the condition persists or gets worse
• a rash or other allergic reaction develops
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN
If swallowed, get medical help or contact a Poison Control Center right away.
Dosage & Administration
DIRECTIONS
• clean the affected area
• apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily
• may be covered with a sterile bandage
Other Information
Store at room temperature
Inactive Ingredient
Petrolatum
Otc - Questions
www.drspharmacyusa.com
* Please review the disclaimer below.
